Description
Product Properties
|
Property Name |
Property Details |
|
Alternative Names |
FCGR3A, FcgRIIIA, FCGR3, Fc gamma RIIIA |
|
Species |
Human |
|
Expression Region |
Gly107–Thr189 |
|
Accession |
AAH17865 |
|
Tag |
C-mFc |
|
Expression System |
HEK293 |
|
Molecular Weight |
The protein has a predicted MW of 35.29 kDa. Due to glycosylation, the protein migrates to 40–50 kDa based on SDS-PAGE result. |
|
Purity |
> 95% as determined by SDS-PAGE and HPLC. |
|
Endotoxin |
< 1.0 EU per μg by the LAL method. |
|
Formulation |
Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
|
Appearance |
Lyophilized Powder |
|
Reconstitution |
Centrifuge the vial before opening. Reconstitute the lyophilized protein with distilled water to a concentration above 100 μg/mL. It is recommended to aliquot into single-use volumes for the first use to avoid repeated freeze-thaw cycles. |
Features
High purity, high bioactivity, low endotoxin, excellent lot-to-lot consistency
Storage
Store at -25°C to -15°C, valid for 1 year upon receipt.
After reconstitution, store under sterile conditions at -85°C to -65°C, valid for 3 months.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.
Inquiry
You may also like
FAQ
The product is for research purposes only and is not intended for therapeutic or diagnostic use in humans or animals. Products and content are protected by patents, trademarks, and copyrights owned by Yeasen Biotechnology. Trademark symbols indicate the country of origin, not necessarily registration in all regions.
Certain applications may require additional third-party intellectual property rights.
Yeasen is dedicated to ethical science, believing our research should address critical questions while ensuring safety and ethical standards.